APCRC - Q Seminar Series Event - Featuring Professor Peter Leedman
| Event Type | Seminar |
|---|---|
| When |
Sep 13, 2012
from 04:00 PM to 05:00 PM |
| Where | Q2.08, QUT Health Clinics, Kelvin Grove |
| Contact Name | Mel Raassina |
| Contact Phone | +61 7 3176 1894 |
| Add event to calendar |
vCal
iCal
|
"MicroRNAs, nuclear receptors and prostate cancer"
Professor Peter Leedman
- Winthrop Professor of Medicine
School of Medicine and Pharmacology - Deputy Director and Director of Translational Research
Western Australian Institute for Medical Research
The University of Western Australia
Peter Leedman is a Professor of Medicine at the University of Western Australia, Director of Translational Research at the Western Australian Institute for Medical Research (WAIMR), Endocrinologist and Director of Research at Royal Perth Hospital. His laboratory has focused on the mechanisms regulating expression of key therapeutic targets in hormone-dependent cancer, including the androgen receptor. His team has uncovered several new members of a complex network of RNA-binding nuclear receptor hormone coregulators and focused on the functional role of specific microRNAs in cancer, including prostate cancer.
"More than Genes: Unveiling the Complexity of RNA
Using Next-Generation Sequencing”
Dr Melanie Lehman
- Postdoctoral Research Fellow (Computational Biologist)
Australian Prostate Cancer Research Centre - Queensland
Institute of Health and Biomedical Innovation
Queensland University of Technology
Melanie Lehman received a BSc from the University of Alberta (cell biotechnology), a graduate certificate in software engineering from Carleton University, a PhD from the University of British Columbia (experimental medicine) and currently holds a position as a postdoctoral research fellow at the Australian Prostate Cancer Research Centre-Queensland. She has worked for the past 10 years in prostate cancer research utilizing computational approaches to analyze genome-wide profiling data from cell lines, animal models, and human tissue samples. Dr. Lehman has integrated data from high density microarrays and next-generation sequencing technologies (RNA, small RNA, ChIP, and DNA) to study the regulation and interaction of protein-coding and non-coding RNAs in steroid response and treatment resistance.
Seminar Talks 12:00pm - 1:00pm
RSVP to prostatecentre@qut.edu.au for catering purposes
